A PYMNTS Company

India: Bayer expects Monsanto acquisition to close soon

By  |  January 17, 2018

German chemical and pharma major Bayer today expressed confidence that it would secure fair trade regulator, the Competition Commission of India’s, nod by April or May for the US$66 billion acquisition of US-based biotech major Monsanto.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    India is one of the 30 countries whose approval is needed for the merger to go through. As many as 14 countries have already approved the merger.

    The company has secured one approval in the US, while one more is pending. The European Union’s clearance is also awaited.

    “We are working with the regulator. We are confident of getting the CCI approval,” said Richard van der Merwe, the senior Bayer representative of South Asia.

    Full Content: The Economic Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.